# REZUROCK
> **NDA214783** · New Drug Application · Sponsor: KADMON PHARMS LLC · Approved 2021-07-16
## Drug
- **FDA Application Number:** NDA214783
- **Application type:** New Drug Application
- **Brand name:** REZUROCK
- **Generic name:** BELUMOSUDIL
- **Active ingredients:** BELUMOSUDIL MESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** KADMON PHARMS LLC
- **Manufacturer:** Kadmon Pharmaceuticals, LLC
- **First approval:** 2021-07-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214783)
---
*AI Analytics · CC0 1.0*